Aspirin and Antiplatelet Agent Resistance: Implications for Prevention of Secondary Stroke

ISSN： 1172-7047

Source： CNS Drugs, Vol.24, Iss.12, 2010-12, pp. : 1027-1040

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet therapy in secondary stroke prevention

By Crawford K Michelle Talbert Robert L

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1609-1613

Informa Healthcare

Access to resources Recommend Favorite

Primary and Secondary Stroke Prevention with Antiplatelet Drugs

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1293-1297

Bentham Science Publishers

Access to resources Recommend Favorite

Aspirin plus dipyridamole effective in secondary stroke prevention

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK: Aspirin, Dipyridamole and Aspirin-Dipyridamole

By Chambers M.

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 577-593

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Antiplatelet Agents Used in the Secondary Prevention of Stroke

By Lenz T.L. Wilson A.F.

Clinical Pharmacokinetics, Vol. 42, Iss. 10, 2003-01 ,pp. : 909-920

Adis International

Access to resources Recommend Favorite